Los Angeles Capital Management LLC Harpoon Therapeutics, Inc. Transaction History

Los Angeles Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$3.54 - $8.08 $196,385 - $448,246	-55,476 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$7.88 - $14.0 $38,296 - $68,040	-4,860 Reduced 8.05%	55,476 $438,000
Q2 2021 Aug 05, 2021	BUY	$13.81 - $23.25 $503,581 - $847,811	36,465 Added 152.76%	60,336 $837,000
Q1 2021 May 05, 2021	BUY	$17.65 - $24.16 $105,423 - $144,307	5,973 Added 33.37%	23,871 $499,000
Q3 2020 Nov 02, 2020	BUY	$11.01 - $18.52 $52,022 - $87,507	4,725 Added 35.87%	17,898 $304,000
Q2 2020 Aug 05, 2020	BUY	$11.11 - $24.72 $146,352 - $325,636	13,173 New	13,173 $218,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.